Triflupromazine

Triflupromazine

Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
MedlinePlus	a600010
ATC code	N05AA05 (WHO)
Legal status
Legal status	US: ℞-only
Identifiers
IUPAC name N,N-dimethyl-3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propan-1-amine
CAS Number	146-54-3 Y
PubChem CID	5568
IUPHAR/BPS	4330
DrugBank	DB00508 N
ChemSpider	5367 N
UNII	RO16TQF95Y
KEGG	D00390 N
ChEBI	CHEBI:9711 N
ChEMBL	ChEMBL570 N
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C18H19F3N2S
Molar mass	352.418 g/mol
3D model (JSmol)	Interactive image
SMILES CN(C)CCCN1c2ccccc2Sc2ccc(cc12)C(F)(F)F
InChI InChI=1S/C18H19F3N2S/c1-22(2)10-5-11-23-14-6-3-4-7-16(14)24-17-9-8-13(12-15(17)23)18(19,20)21/h3-4,6-9,12H,5,10-11H2,1-2H3 N Key:XSCGXQMFQXDFCW-UHFFFAOYSA-N N
NY (what is this?)  (verify)

WikiDoc Resources for Triflupromazine
Articles
Most recent articles on Triflupromazine Most cited articles on Triflupromazine Review articles on Triflupromazine Articles on Triflupromazine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Triflupromazine Images of Triflupromazine Photos of Triflupromazine Podcasts & MP3s on Triflupromazine Videos on Triflupromazine
Evidence Based Medicine
Cochrane Collaboration on Triflupromazine Bandolier on Triflupromazine TRIP on Triflupromazine
Clinical Trials
Ongoing Trials on Triflupromazine at Clinical Trials.gov Trial results on Triflupromazine Clinical Trials on Triflupromazine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Triflupromazine NICE Guidance on Triflupromazine NHS PRODIGY Guidance FDA on Triflupromazine CDC on Triflupromazine
Books
Books on Triflupromazine
News
Triflupromazine in the news Be alerted to news on Triflupromazine News trends on Triflupromazine
Commentary
Blogs on Triflupromazine
Definitions
Definitions of Triflupromazine
Patient Resources / Community
Patient resources on Triflupromazine Discussion groups on Triflupromazine Patient Handouts on Triflupromazine Directions to Hospitals Treating Triflupromazine Risk calculators and risk factors for Triflupromazine
Healthcare Provider Resources
Symptoms of Triflupromazine Causes & Risk Factors for Triflupromazine Diagnostic studies for Triflupromazine Treatment of Triflupromazine
Continuing Medical Education (CME)
CME Programs on Triflupromazine
International
Triflupromazine en Espanol Triflupromazine en Francais
Business
Triflupromazine in the Marketplace Patents on Triflupromazine
Experimental / Informatics
List of terms related to Triflupromazine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Triflupromazine (Vesprin) is an antipsychotic medication of the phenothiazine class. Among different effects of triflupromazine indication for use of this drug is severe emesis. Due to its potential side effects (triflupromazine has higher risk for side effects than many other antipsychotics) it is not gold standard in antiemetic therapy.

Serious side effects of trifluproamzine can be akathisia and tardive dyskinesia as well as the rare, but potentially fatal, neuroleptic malignant syndrome.